CLINICAL_TRIALS
trial_result
· 2026-04-27
Clinical Trial Update: A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight [Phase 3]
Summary
Phase 3 trial assessing semaglutide for weight loss in adults with obesity and type 2 diabetes completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Obesity, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2026-04-27